Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells
Jing Wang,
No information about this author
Yaqin Hou,
No information about this author
Lijun Mu
No information about this author
et al.
International Immunopharmacology,
Journal Year:
2024,
Volume and Issue:
143, P. 113570 - 113570
Published: Nov. 15, 2024
Language: Английский
The Role of Mesenchymal Stromal Cells in the Treatment of Rheumatoid Arthritis
Cells,
Journal Year:
2024,
Volume and Issue:
13(11), P. 915 - 915
Published: May 25, 2024
Rheumatoid
arthritis
(RA)
is
a
chronic
inflammatory
joint
disease
characterised
by
the
formation
of
hyperplastic
pannus,
as
well
cartilage
and
bone
damage.
The
pathogenesis
RA
complex
involves
broad
interactions
between
various
cells
present
in
inflamed
synovium,
including
fibroblast-like
synoviocytes
(FLSs),
macrophages,
T
cells,
among
others.
Under
conditions,
these
are
activated,
further
enhancing
responses
angiogenesis
promoting
degradation.
Novel
treatment
methods
for
greatly
needed,
mesenchymal
stromal
(MSCs)
have
been
suggested
promising
new
regenerative
immunomodulatory
treatment.
In
this
paper,
we
MSCs
RA-FLSs,
macrophages
summarise
studies
examining
use
preclinical
clinical
studies.
Language: Английский
The absolute number of circulating Treg cells is reduced in difficult-to-treat RA patients and is ameliorated by low-dose IL-2
Huanhuan Yan,
No information about this author
Xiaoyu Zi,
No information about this author
Huer Yan
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 6, 2025
Circulating
regulatory
T
cells
(Tregs)
are
closely
related
to
immune
tolerance
and
maintenance
of
homeostasis.
Perhaps,
there
is
a
unique
cell
phenotype
for
difficult-to-treat
rheumatoid
arthritis
(D2T
RA).
Low-dose
interleukin-2
(IL-2)
has
been
considered
the
treatment
autoimmune
diseases.
This
study
focused
on
uniqueness
D2T
RA
lymphocyte
subsets
feasibility
low-dose
IL-2
therapy.
Participants
included
1,042
patients
who
were
divided
into
three
groups
according
presence
or
absence
their
response
in
last
6
months-new
group,
treated
group-and
339
healthy
controls
(HCs).
A
total
381
patients-107,
151,
123
each
experimental
groups-received
[0.5
million
international
units
(MIU)
per
day,
subcutaneous
injection
from
day
1
5].
The
absolute
numbers
peripheral
blood
detected
by
flow
cytometry
(FCM)
serum
cytokine
levels
bead
array
(CBA).
number
T,
CD4+
Treg
group
was
lower
than
that
HC,
new,
groups.
Compared
with
HC
new
ratio
Th17/Treg
increased.
treated,
had
higher
HC.
negatively
correlated
disease
activity
index.
could
be
increased
therapy
without
any
side
effects.
lymphocytes
reduced,
especially
cells,
resulting
shift
balance
effector
cells/Treg
toward
which
ameliorated
obvious
Language: Английский
Restoring immune tolerance in pre-RA: immunometabolic dialogue between gut microbiota and regulatory T cells
Anqi Gao,
No information about this author
Ruihe Wu,
No information about this author
Yanfei Mu
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 20, 2025
Rheumatoid
arthritis
(RA)
is
a
complex
chronic
autoimmune
disease
that
remains
incurable
for
most
patients.
With
advances
in
our
understanding
of
the
disease’s
natural
history,
concept
pre-RA
has
emerged
as
window
opportunity
to
intervene
before
irreversible
joint
damage
occurs.
Numerous
studies
have
indicated
key
step
driving
autoimmunity
early
lies
at
an
extra-articular
site,
which
closely
related
regulatory
T
(Treg)
cell-established
immune
tolerance
gut
microbiota.
The
intricate
immunometabolic
crosstalk
between
Treg
cells
and
microbiota
beginning
be
understood,
with
re-recognition
metabolic
sensors
recent
years.
In
future,
deciphering
their
dialogue
may
help
elucidate
underlying
mechanisms
pre-RA.
Identifying
novel
biological
pathways
stage
will
bring
insights
into
restoring
tolerance,
thereby
potentially
curing
or
preventing
onset
RA.
Language: Английский
Propofol alleviates traumatic brain injury through regulating Th17/Treg balance by activation of the AMPK/SIRT1 pathway
Dan Wang,
No information about this author
Hongyu Sun,
No information about this author
Kerong Hai
No information about this author
et al.
Toxicology Mechanisms and Methods,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 11
Published: April 2, 2025
Traumatic
brain
injury
(TBI),
a
prevalent
neurological
disorder
in
clinical
practice,
is
primarily
induced
by
external
trauma.
Propofol
has
been
reported
to
alleviate
the
symptoms
associated
with
TBI.
In
this
study,
TBI
model
was
established
mice
using
controlled
cortical
impact
(CCI)
method.
After
treatment
propofol
and
BML-275,
neuronal
damage
assessed
through
modified
Neurological
Severity
Score
(mNSS),
Hematoxylin
Eosin
(HE)
staining,
Nissl
staining.
To
investigate
role
of
AMPK/SIRT1
pathway
propofol-regulated
TBI,
AMPKα-silenced
vectors
overexpressed
SIRT1
were
transfected.
Western
blot
performed
evaluate
expression
proteins
involved
pyroptosis
markers.
The
regulatory
Th17/Treg
balance
examined
detecting
key
transcription
factors
RORγt
FOXP3
immunofluorescent
staining
RT-qPCR.
Enzyme-linked
immunosorbent
assay
(ELISA)
used
measure
IL-17
IL-10
concentrations.
Results
showed
that
significantly
reduced
model,
an
effect
reversed
BML-275.
Moreover,
mitigated
downregulating
Caspase-1
GSDMD-N
post-TBI.
inhibited
Th17
differentiation
while
promoting
Treg
modulating
RORγt/FOXP3
IL-17/IL-10
levels.
Silencing
AMPKα
markedly
diminished
propofol's
effects
on
differentiation,
these
being
upon
overexpression.
suppressed
regulation
via
activation
pathway.
These
findings
suggest
exerts
protective
against
following
potentially
modulation
signaling
Language: Английский
Dendritic cells in multiple myeloma: from immune evasion to therapeutic potential
Mark L. Jordan,
No information about this author
Johannes Morschl,
No information about this author
Stella E. Autenrieth
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 17, 2025
Multiple
myeloma
(MM)
is
a
type
of
hematologic
cancer
characterized
by
the
uncontrolled
clonal
expansion
plasma
cells
in
bone
marrow
(BM).
This
leads
to
significant
dysfunction
and
suppression
immune
system
affected
patients.
Myeloma
employ
sophisticated
strategies
manipulate
non-immune
cells,
evading
surveillance
enhancing
their
survival.
One
key
factor
this
evasion
disruption
dendritic
cell
(DC)-mediated
mechanisms.
Extensive
evidence
indicates
that
presence
DC
numbers
are
notably
reduced,
phenotype
function
altered,
impairing
ability
present
antigens
activate
robust
T-cell
responses
effectively.
Despite
rapid
advances
MM
treatment,
with
promising
such
as
DC-based
vaccines
being
already
achieved,
remains
substantial
hurdle,
associated
or
contributing
poor
therapeutic
outcomes,
disease
relapse,
MM’s
persistence
an
incurable
disease.
To
address
these
challenges,
it
essential
understand
intricate
mechanisms
through
which
transform
DCs
into
“accomplices,”
undermining
responses.
review
comprehensively
summarizes
current
understanding
role
MM.
Additionally,
evaluates
potential
anti-MM
immunotherapy,
discussing
persistent
challenges
highlighting
emerging
perspectives
may
lead
breakthroughs
for
improved
patient
outcomes.
Language: Английский
Dioscin alleviates aplastic anemia through regulatory T cells promotion
Hematology,
Journal Year:
2024,
Volume and Issue:
29(1)
Published: March 11, 2024
Objectives:
Aplastic
anemia
(AA)
is
one
of
the
immune-mediated
bone
marrow
failure
disorders
caused
by
multiple
factors,
including
inability
CD4
+
CD25
regulatory
T
cells
(Tregs)
to
negatively
regulate
cytotoxic
lymphocytes
(CTLs).
Dioscin
a
natural
steroid
saponin
that
has
similar
structure
hormones.
The
purpose
this
study
look
into
effect
on
functions
CD25+
Tregs
in
AA
mouse
model
and
explore
its
underlying
mechanism.
Language: Английский
Farnesyl pyrophosphate synthase inhibitors with antiosteoporosis efficacy in ovariectomized rats: A mixed binding approach beyond bisphosphonates
European Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
276, P. 116679 - 116679
Published: July 14, 2024
Language: Английский
The balance between helper T 17 and regulatory T cells in osteoimmunology and relevant research progress on bone tissue engineering
Immunity Inflammation and Disease,
Journal Year:
2024,
Volume and Issue:
12(9)
Published: Sept. 1, 2024
Abstract
Background
Bone
regeneration
is
a
well‐regulated
dynamic
process,
of
which
the
prominent
role
immune
system
on
bone
homeostasis
more
and
revealed
by
recent
research.
Before
fully
activation
remodeling
cells,
needs
to
clean
up
microenvironment
in
facilitating
repair
initiation.
Furthermore,
this
must
be
maintained
properly
various
mechanisms
over
entire
process.
Objective
This
review
aims
summarize
T‐helper
17/Regulatory
T
cell
(Th17/Treg)
balance
discuss
relevant
progress
tissue
engineering.
Results
The
response
early
stages
crucial,
especially
impact
Th17/Treg
osteoclasts,
mesenchymal
stem
cells
(MSCs),
osteoblasts
activity.
By
virtue
these
knowledge
advancements,
innovative
approaches
engineering,
such
as
nano‐structures,
hydrogel,
exosomes,
are
designed
influence
thereby
augment
regeneration.
Conclusion
Targeting
promising
strategy
for
developing
new
treatments
enhance
regeneration,
thus
offering
potential
breakthroughs
injury
clinics.
Language: Английский
The Nexus Between Traditional Chinese Medicine and Immunoporosis: Implications in the Treatment and Management of Osteoporosis
Xiaolei Ding,
No information about this author
Jie Yang,
No information about this author
Yuchi Wei
No information about this author
et al.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 3, 2024
ABSTRACT
Osteoporosis
(OP)
is
a
globally
prevalent
bone
disease
characterized
by
reduced
mass
and
heightened
fracture
risk,
posing
significant
health
economic
challenge
to
aging
societies
worldwide.
Osteoimmunology—an
emerging
field
of
study—investigates
the
intricate
relationship
between
skeletal
immune
systems,
providing
insights
into
system's
impact
on
progression.
Recent
research
has
demonstrated
essential
roles
played
various
cells
(T
cells,
B
macrophages,
dendritic
mast
granulocytes,
innate
lymphoid
cells)
in
regulating
metabolism,
homeostasis,
formation,
remodeling
through
interactions
with
osteoclasts
(OC)
osteoblasts
(OB).
These
findings
underscore
that
osteoimmunology
provides
an
theoretical
framework
for
understanding
pathogenesis
disorders,
including
OP.
Traditional
Chinese
medicine
(TCM)
its
active
ingredients
have
clinical
value
OP
treatment.
Unfortunately,
despite
their
striking
multieffect
pathways
pharmacological
field,
current
not
yet
summarized
them
comprehensive
detailed
manner
respect
interventional
diseases,
especially
Consequently,
this
review
addresses
recent
studies
mechanisms
which
communication
molecules
contribute
development.
Additionally,
it
explores
potential
therapeutic
benefits
TCM
components
treating
from
perspective
osteoimmunology.
The
objective
provide
enhances
immune‐related
diseases
facilitate
development
novel
strategies.
Language: Английский